The Journal of Urology – Editor’s Choice Innovative Management of Urologic Cancers (2025) Prasad

Description

Analysis of current advancements in urologic oncology, focusing on chemoablation therapy (UGN-102) for low-grade non-muscle-invasive bladder cancer (NMIBC), the application of novel implantable microdevices for personalized drug response evaluation in prostate cancer, and the utility of PSMA PET/CT imaging for detecting biochemical recurrence at low PSA levels after radical prostatectomy.